Influence of CTLA-4/CD28/ICOS gene polymorphisms on the susceptibility to cervical squamous cell carcinoma and stage of differentiation in the Polish population

Human Immunology

Volumn 71, Issue 2, 2010, Pages 195-200

  Pawlak, Edyta ^a   Karabon, Lidia ^a   Wlodarska Polinska, Iwona ^b   Jedynak, Anna ^a   Jonkisz, Anna ^b   Tomkiewicz, Anna ^a   Kornafel, Jan ^b   Stepien, Marcin ^b   Ignatowicz, Agnieszka ^b   Lebioda, Arleta ^b   Dobosz, Tadeusz ^b   Frydecka, Irena ^a,b  

^a INSTITUTE OF IMMUNOLOGY AND EXPERIMENTAL THERAPY   (Poland)

^b WROCLAW MEDICAL UNIVERSITY   (Poland)

Author keywords

CD28; Cervical squamous cell carcinoma; CTLA 4; Gene polymorphism; ICOS

Indexed keywords

CD28 ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; INDUCIBLE COSTIMULATOR PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CANCER GRADING; CANCER RISK; CANCER STAGING; CONTROLLED STUDY; FEMALE; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; HOMOZYGOTE; HUMAN; IMMUNOPATHOGENESIS; MAJOR CLINICAL STUDY; MUTATION RATE; MUTATIONAL ANALYSIS; POLAND; PRIORITY JOURNAL; TUMOR DIFFERENTIATION; UTERINE CERVIX CARCINOMA;

ANTIGENS, CD; ANTIGENS, CD28; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; CARCINOMA, SQUAMOUS CELL; CELL DIFFERENTIATION; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LINKAGE DISEQUILIBRIUM; NEOPLASM STAGING; POLAND; POLYMORPHISM, SINGLE NUCLEOTIDE; UTERINE CERVICAL NEOPLASMS;

EID: 74449089797     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humimm.2009.11.006     Document Type: Article

References (52)

1. Vizcaino A.P., Moreno V., Bosch F.X., Muñoz N., Barros-Dios X.M., Borras J., et al. International trends in incidence of cervical cancer. II. Squamous-cell carcinoma. Int J Cancer 86 (2000) 429-435
2. Carreno B.M., and Collins M. The B7 family of ligands and its receptors. New pathway for costimulation and inhibition of immune responses. Annu Rev Immunol 20 (2002) 29-53
3. Wlodarska-Polinska I., Frydecka I., Bocko D., Kosmaczewska A., Ciszak L., and Kornafel J. Alterations of the expression of signal-transducing CD3ζ and costimulatory CD28 molecule in peripheral blood T lymphocytes in patients with cervical cancer. Adv Clin Exp Med 13 (2004) 589-594
4. Cosiski-Marana H.R., da Silva S.J., and de Andrade M.J. NK cell activity in the presence of IL-12 is a prognostic assay to neoadjuvant chemotherapy in cervical cancer. Gynecol Oncol 78 (2000) 318-323
5. Hutloff A., Dittrich A.M., Beier K.C., Eljaschewitsch B., Kraft R., Anagnostopoulos I., et al. ICOS is an inducible T-cell co-stimulator structurally and functionally related to CD28. Nature 397 (1999) 263-266
6. Beier K.C., Hutloff A., Dittrich A.M., Heuck C., Rauch A., Büchner K., et al. Induction, binding specificity and function of human ICOS. Eur J Immunol 30 (2000) 3707-3717
7. Walunas T.L., Lenschow D.J., Bakker C.Y., Linsley P.S., Freeman G.J., Green J.M., et al. CTLA-4 can function as a negative regulator of T cell activation. Immunity 5 (1994) 405-413
8. Leach D.R., Krummel M.F., and Allison J.P. Enhancement of antitumor immunity by CTLA-4 blockade. Science 271 (1996) 1734-1736
9. Hurwitz A.A., Foster B.A., Kwon E.D., Truong T., Choi E.M., Greenberg N.M., et al. Combination immunotherapy of primary prostate cancer in a transgenic mouse model using CTLA-4 blockade. Cancer Res 60 (2000) 2444-2448
10. van Elsas A., Hurwitz A.A., and Allison J.P. Combination immunotherapy of B16 melanoma using anti cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) and granulocyte/macrophage colony stimulating factor (GM-CSF)-producing vaccines induces rejection of subcutaneous and metastatic tumors accompanied by autoimmune depigmentation. J Exp Med 190 (1999) 355-366
11. O'Day S.J., Hamid O., and Urba W.J. Targeting cytotoxic T-lymphocyte antigen-4 (CTLA-4): A novel strategy for the treatment of melanoma and other malignancies. Cancer 110 (2007) 2614-2627
12. Maker A.V., Phan G.Q., Attia P., Yang J.C., Sherry R.M., Topalian S.L., et al. Tumor regression and autoimmunity in patients treated with cytotoxic T lymphocyte-associated antigen 4 alockade and interleukin 2: A phase I/II study. Ann Surg Oncol 12 (2005) 1005-1016
13. Frydecka I., Kosmaczewska A., Bocko D., Ciszak L., Wolowiec D., Kuliczkowski K., et al. Alterations of the expression of T-cell-related costimulatory CD28 and downregulatory CD152 (CTLA-4) molecules in patients with B-cell chronic lymphocytic leukaemia. Br J Cancer 17 (2004) 2042-2048
14. + tumourinfiltrating lymphocytes (TIL) from patients with ovarian and other types of peritoneal carcinoma. Clin Exp Immunol 119 (2000) 19-27
15. Kim Ch.W., Choi S.H., Chung E.J., Lee M.J., Byun E.K., Ryu M.H., et al. Alteration of signaltransducing molecules and phenotypical characteristics in peripheral blood lymphocytes from gastric carcinoma patients. Pathobiology 67 (1999) 123-128
16. Motta M., Rassenti L., Shelvin B.J., Lerner S., Kipps T.J., Keating M.J., et al. Increased expression of CD152 (CTLA-4) by normal T lymphocytes in untreated patients with B-cell chronic lymphocytic leukaemia. Leukemia 19 (2005) 1788-1793
17. Wang X.B., Zhao X., Giscombe R., and Lefvert A.K. A CTLA-4 gene polymorphism at position -318 in the promoter region affects the expression of protein. Genes Immun 3 (2002) 233-234
18. Chistiakov D.A., Savost'Anov K.V., Turakulov R.I., Efremov I.A., and Demurov L.M. Genetic analysis and functional evaluation of the C/T(-319) and A/G(-1661) polymorphisms of the CTLA-4 gene in patients affected with Graves' disease. Clin Immunol 118 (2006) 233-242
19. Ligers A., Teleshova N., Masterman T., Huang W.X., and Hillert J. CTLA-4 gene expression is influenced by promoter and exon 1 polymorphisms. Genes Immun 2 (2001) 145-152
20. Nistico L., Buzzetti R., Pritchard L.E., Van der Auwera B., Giovannini C., Bosi E., et al. The CTLA-4 gene region of chromosome 2q33 is linked to, and associated with, type 1 diabetes. Belgian Diabetes Registry. Hum Mol Genet 5 (1996) 1075-1080
21. Kouki T., Sawai Y., Gardine C.A., Fisfalen M.E., Alegre M.L., and DeGroot L.J. CTLA-4 gene polymorphism at position 49 in exon 1 reduces the inhibitory function of CTLA-4 and contributes to the pathogenesis of Graves' disease. J Immunol 165 (2000) 6606-6611
22. Anjos S., Nguyen A., Ounissi-Benkalha H., Tessier M.C., and Polychronakos C. A common autoimmunity predisposing signal peptide variant of the cytotoxic T-lymphocyte antigen 4 results in inefficient glycosylation of the susceptibility allele. J Biol Chem 277 (2002) 46478-46486
23. Wang X.B., Kakoulidou M., Giscombe R., Qiu Q., Huang D., Pirskanen R., et al. Abnormal expression of CTLA-4 by T cells from patients with myasthenia gravis: Effect of an AT-rich gene sequence. J Neuroimmunol 130 (2002) 224-232
24. Ueda H., Howson J.M., Esposito L., Heward J., Snook H., Chamberlain G., et al. Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease. Nature 423 (2003) 506-510
25. Karabon L., Kosmaczewska A., Bilinska M., Pawlak E., Ciszak L., Jedynak A., et al. The CTLA-4 gene polymorphisms are associated with CTLA-4 protein expression levels in multiple sclerosis patients and with susceptibility to disease. Immunology 128 (2009) e787-e796
26. Daroszewski J., Pawlak E., Karabon L., Frydecka I., Jonkisz A., Slowik M., et al. Soluble CTLA-4 receptor an immunological marker of Graves' disease and severity of ophthalmopathy is associated with CTLA-4 JO31 and CT60 gene polymorphisms. Eur J Endocrinol 161 (2009) 787-793
27. Ghaderi A., Yeganeh F., Kalantari T., Talei A.R., Pezeshki A.M., Doroudchi M., et al. Cytotoxic T lymphocyte antigen-4 gene in breast cancer. Breast Cancer Res Treat 86 (2004) 1-7
28. Erfani N., Razmkhah M., Talei A.R., Pezeshki A.M., Doroudchi M., Monabati A., et al. Cytotoxic T lymphocyte antigen-4 promoter variants in breast cancer. Cancer Genet Cytogenet 165 (2006) 114-120
29. Wang L., Li D., Fu Z., Li H., Jiang W., and Li D. Association of CTLA-4 gene polymorphisms with sporadic breast cancer in Chinese Han population. BMC Cancer 7 (2007) 173-179
30. Li H., Fu Z.K., Wang L.H., et al. Association of cytotoxic T lymphocyte antigen-4 gene polymorphism with susceptibility to breast cancer. Xi. Bao Yu Fen Zi Mian Yi Xue Zhi 24 (2008) 282-284
31. Zheng C., Huang D., Liu L., Bjoörkholm M., Holm G., Yi Q., et al. Cytotoxic T-lymphocyte antigen-4 microsatellite polymorphism is associated with multiple myeloma. Br J Haematol 112 (2001) 216-218
32. Wong Y.K., Chang K.W., Cheng C.Y., and Liu C.J. Association of CTLA-4 gene polymorphism with oral squamous cell carcinoma. J Oral Pathol Med 35 (2006) 51-54
33. -CTLA-4-ICOS genes: Association with non-Hodgkin's lymphoma. Br J Haematol 129 (2005) 784-790
34. Suwalska K., Pawlak E., Karabon L., Tomkiewicza A., Dobosz T., Urbaniak-Kujda D., et al. Association studies of CTLA-4, CD28, and ICOS gene polymorphisms with B-cell chronic lymphocytic leukemia (B-CLL) in the Polish population. Hum Immunol 69 (2007) 193-201
35. Cheng T.Y., Lin J.T., Chen L.T., Shun C.T., Wang H.P., Lin M.T., et al. Association of T-cell regulatory gene polymorphisms with susceptibility to gastric mucosa-associated lymphoid tissue lymphoma. J Clin Oncol 24 (2006) 3483-3489
36. Cozar J.M., Romero J.M., Aptsiauri N., Vazquez F., Vilchez J.R., Tallada M., et al. High incidence of CTLA-4 AA (CT60) polymorphism in renal cell cancer. Hum Immunol 68 (2007) 698-704
37. Solerio E., Tappero G., Iannace L., Matullo G., Ayoubi M., Parziale A., et al. CTLA4 gene polymorphism in Italian patients with colorectal adenoma and cancer. Dig Liver Dis 37 (2005) 170-175
38. Welsh M.M., Applebaum K.M., Spencer S.K., Perry A.E., Karagas M.R., and Nelson H.H. CTLA4 variants, UV-induced tolerance, and risk of non-melanoma skin cancer. Cancer Res 69 (2009) 6158-6163
39. Su T.H., Chang T.Y., Lee Y.J., Chen C.K., Liu H.F., Chu C.C., et al. CTLA-4 gene and susceptibility to human papillomavirus-16-associated cervical squamous cell carcinoma in Taiwanese women. Carcinogenesis 28 (2007) 1237-1240
40. Guzman V.B., Morgun A., Shulzhenko N., Mine K.L., Gonçalves-Primo A., Musatti C.C., et al. New approach reveals CD28 and IFNG gene interaction in the susceptibility to cervical cancer. Hum Mol Genet 17 (2008) 1838-1844
41. Gough S.C.L., Walker L.S.K., and Sansom D.M. CTLA4 gene polymorphism and autoimmunity. Immunol Rev 204 (2005) 102-115
42. Ihara K., Ahmed S., Nakao F., Kinukawa N., Kuromaru R., Matsuura N., et al. Association studies of CTLA-4, CD28, and ICOS gene polymorphisms with type 1 diabetes in the Japanese population. Immunogenetics 53 (2001) 447-454
43. Włodarska-Polińska I., Pawlak E., Suwalska K., et al. Lack of association between CD28 gene polymorphism and cervical cancer in Lower Silesian population. Adv Clin Exp Med 15 (2006) 595-598
44. Tavassoli F.A., Deville P., and World Health Organization classification of tumours. Pathology and genetics of tumours of the breast and female genital organs (2003), Lyon' IARC Press 138-9
45. International Federation of Gynecology and Obstetrics. FIGO stages-1988 revision. Gynecol Oncol 35 (1989) 125-127
46. Bardin A., Vaccarella S., Clifford G.M., Lissowska J., Rokosz M., Bobkiewicz P., et al. Human papillomavirus infection in women with and without cervical cancer in Warsaw, Poland. Eur J Cancer 44 (2008) 557-564
47. Görander S., Lagergård T., Romanik M., Viscidi R.P., Martirosian G., and Liljeqvist J. Seroprevalences of herpes simplex virus type 2, five oncogenic human papillomaviruses, and Chlamydia trachomatis in Katowice, Poland. Clin Vacc Immunol 15 (2008) 675-680
48. Szostek S., Klimek M., Zawilinska B., and Kosz-Vnenchak M. Genotype-specific human papillomavirus detection in cervical smears. Acta Biochim Polonica 55 (2008) 687-692
49. Clifford G.M., Gallus S., Herrero R., Muńoz N., Snijders P.J.F., Vaccarella S., et al. Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys: A pooled analysis. Lancet 366 (2005) 991-998
50. Roberts C.C., Tadesse A.S., Sands J., Halvorsen T., Schofield T.L., Dalen A., et al. Detection of HPV in Norwegian cervical biopsy specimens with type specific PCR and reverse line blot assays. J Clin Virol 36 (2006) 277-282
51. al-Salach W., Delvenne P., Greimers R., Fridman V., Doyen J., and Boniver J. Assessment of Ki-67 antigen immunostaining in squamous intraepithelial lesions of the uterine cervix. Correlation with the histologic grade and human papillomavirus type. Am J Clin Pathol 104 (1995) 154-160
52. Guzman V.B., Morgun A., Shulzhenko N., Mine K.L., Goncalves-Primo A., Musatti C.C., et al. Characterization of CD28, CTLA4 and ICOS polymorphisms in three Brazilian ethnic groups. Hum Immunol 66 (2005) 773-776